Investors looking forward to a better year for the stock market might figure the worst performers will deliver the best gains, but history indicates otherwise.
Yahoo Finance Live anchor Julie Hyman reports on Novavax replacing Stanley Erck with John Jacobs as the new president and CEO of the biotechnology company.
Novavax (NVAX) initiates a mid-stage study evaluating its COVID-19-Influenza combination and standalone influenza vaccines in adults aged 50 through 80 years.
Triple-digit returns could be just a click away from the buy button.
Novavax Inc. NVAX, +7.28% said Friday that it has initiated a Phase 2 trial for its COVID-19-Influenza Combination (CIC) vaccine candidate, as well as for a stand-alone flu vaccine candidate. The biot

Better Recovery Story Buy: Teladoc vs. Novavax

05:30am, Wednesday, 28'th Dec 2022
These stocks each sank more than 70% this year.
You don't need a mountain of money to grow your wealth on Wall Street.

Three Pharma Stocks to Sell Before They Die

05:20pm, Saturday, 24'th Dec 2022
As we head into New Year 2023, we wanted to take a look at some of the top biotech blunders of the last several months. While many biotech stocks can hold immense profit potential, others can wipe out

Is There Any Hope for Novavax?

11:00am, Thursday, 22'nd Dec 2022 The Motley Fool
The near term looks complicated for this biotech player.

Is There Any Hope for Novavax?

06:00am, Thursday, 22'nd Dec 2022
The near term looks complicated for this biotech player.
Gainers Allarity Therapeutics, Inc. (NASDAQ: ALLR) gained 240% to $0.90. Allarity Therapeutics, last month, posted a Q3 loss of $0.68 per share. Maxar Technologies Inc. (NYSE: MAXR) shares jumped 12

Novavax stock continues to trend lower

05:50pm, Friday, 16'th Dec 2022
Shares of Novavax plunged to a two-year low on news that the company had to return $112.5 million to the UK government for unused vaccines.

Company News for Dec 16, 2022

02:39pm, Friday, 16'th Dec 2022 Zacks Investment Research
Companies in The News Are: NFLX,WBD,NVAX,META
Gainers Minim, Inc. (NASDAQ: MINM) shares rose 66.5% to $0.2903 in pre-market trading after gaining over 10% on Thursday. Minim, last month, reported worse-than-expected results. Lanvin Group (NASDAQ
S&P, Nasdaq, Dow futures mixed after post-Fed selloff. SPAC DWAC falls after `major announcement' is a Trump digital trading card. Southwest Airlines reaches a deal with the largest union.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE